Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Angel Investors in United Kingdom in January 2026

Last updated: Jan 2026 A list of 50 angel investors that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.

Top 50 Medical Angel Investors in United Kingdom in January 2026

Investor	Medical United Kingdom investments
Jonathan Milner	12
Ian Hogarth	3
Mark Bamforth	2
Taavet Hinrikus	2
Michael Pennington	2
Will Martin	2
Ariel Poler	2
Will Brooks	2
Nicholas Edwards	2
Alexander Chesterman	2
Jan Hruska	2
Matt Robinson	2
Matt Clifford	2
Jonathan Lenson	1
Errol Damelin	1
Maurice Ferre, M.D.	1
Bob Davis	1
Thomas Dyrberg	1
John Lloyd	1
Jim Breyer	1
Flavien Kulawik	1
Pa Nolan	1
Arthur Chen	1
Emilio Püschmann	1
Tracy Doree	1
Evelyn Bourke	1
Nicolaus Henke	1
John Taysom	1
Adam Niewinski	1
Henry Engelhardt	1
Peer Schatz	1
Will Armitage	1
Brendan O'Driscoll	1
Sidar Sahin	1
Andrew MacKay	1
Elan Katz	1
Robert Taub	1
Henry Carleton	1
Nigel Rudd	1
Sachin Agrawal	1
David Prior	1
Johnathan Matlock	1
Jim Mellon	1
Brian Kennedy	1
Carlos Ballarati	1
Yusuf Hamied	1
Brian Souter	1
Fred Moll, M.D	1
Anand Mahindra	1
David Evans	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Spain

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
Exciting Instruments — We're on a mission to simplify single-molecule fluorescence spectroscopy and make it accessible to all. Find out more about our company, our products and what makes us different.

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

Investment focus

Software, E-Commerce, Internet
Seed, Pre-Seed, Series A
United Kingdom, United States, Germany

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Unitary — We detect harmful content with context-aware AI to keep brands and platforms safe online.
Fabric — One home for your digital world. Your second brain. A file explorer and workspace for the internet age. All your drives, clouds, notes, screenshots, links, and files in one calm, minimal app. No organizing required. Never forget anything again.

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

Investment focus

Health Care, Medical, Biotechnology
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
PneumoWave — PneumoWave is developing real-time monitoring solutions to allow patients with respiratory conditions and their doctors to track their respiratory rates and performance out of hospital, at home and at work. Combining proprietary sensor technology and an innovative AI driven digital therapeutic software platform, PneumoWave's technologyenables doctors to rationalise medication use, identify early signs of deterioration, reduce or shorten hospital admissions and reduce face to face appointments.
Thymmune Therapeutics — Thymmune Therapeutics is developing a machine learning-driven thymic cell engineering platform to restore normal immune function in aging and disease.

Taavet Hinrikus is based out of London, England and is the Partner of Plural Platform and Board Member of CoMind. Taavet previously worked at Wise as a Chairman and Co-founder. Taavet Hinrikus attended INSEAD.

Investment focus

FinTech, Software, Financial Services
Seed, Series A, Series B
United Kingdom, United States, Estonia

Portfolio highlights

Juro — Juro is an all-in-one contract automation platform that helps legal and business users to agree & manage contracts in one unified workspace.
Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
Skeleton Technologies — Skeleton Technologies is the global leader in ultracapacitor & supercapacitor energy storage and helps companies in automotive, transportation, grid, and industry to save energy.

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B. Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

Investment focus

Software, SaaS, Financial Services
Seed, Pre-Seed, Funding Round
United Kingdom, United States, Spain

Portfolio highlights

Hubflo — Hubflo is building an all-in-one work OS to help small businesses manage their business. Instead of having 10 complicated and expensive pieces of software, Hubflo offers SMB everything they need to run their business (CRM, projects, invoicing, expenses...) in a single comprehensive, simple and affordable platform.
FUEL — Where everlasting fanbases are built
Sidekick — Expertly-managed portfolios for the modern investor

Will Martin - Founder and Director @ Portfolio Ventures

Investment focus

Financial Services, Software, FinTech
Seed, Funding Round, Series A
United Kingdom, Japan, United States

Portfolio highlights

Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Loadsure — Loadsure is a spot freight cargo insurance company.
Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

Investment focus

Software, Social Media, Internet
Seed, Series A, Angel
United States, Spain, Mexico

Portfolio highlights

Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
Kiwibot — Delivery robots to optimize your business and deliver safely and timely to your customers.
Grin Scooters — Grin Scooters is a software company that operates network of operational shared electric scooters. Currently, Grin only operates in Mexico City, Guadalajara, Monterrey, Sao Paulo and Bogota but it has plans to expand to other cities throughout Latin America.

Will Brooks - Founder & Director @ Portfolio Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Disputed — FinLegal is legaltech for the business of disputes. Our solutions allow you to fund and insure your litigation through litigation funding and after-the-event insurance, automate volume and class actions and get more clients through working with marketing service providers.
Robin — Robin AI is a legal tech company based in London, made up of engineers, lawyers, scientists and operations specialists.
Marshmallow — Digital-first car insurance company with a mission to deliver great prices, service, and coverage.

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Alex Chesterman is the Co-Founder of Houseful. Alex Chesterman attended the University College London.

Investment focus

E-Commerce, FinTech, Financial Services
Seed, Pre-Seed, Series A
United Kingdom, France

Portfolio highlights

Zefir — Zefir aims to expand the realm of possibilities for millions of European homeowners. We make home-selling simpler, faster and more certain by buying the property directly from you. Selling a home is now just a few clicks away.
Pharmacierge — Pharmacierge is the digital e-prescribing service chosen by private clinicians to deliver medication to their patients throughout the UK and worldwide. Clinicians create and transfer e-prescriptions to our pharmacy near London's Harley Street, for free delivery to their patients either the same day or next weekday
Vyne Technologies — Vyne Technologies is the specialist account-to-account payments platform.

Jan Hruska

Investment focus

Medical, Health Care, Life Science
Seed, Funding Round
United Kingdom

Portfolio highlights

Oxford Medical Products — Oxford Medical Products is a UK-based biotechnology start-up revolutionising the weight-loss treatment space with its hydrogel-based technology.

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
United Kingdom, United States, Germany

Portfolio highlights

Malga — Malga is an online payment platform that offers fraud protection and payment split services.
Feather — Feather gives you insurance advice for expats in Germany. Our digital insurance agent will help you get the right insurance policies for your need.
Malga — Instant access to multiple payment providers with a single integration

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Pre-Seed, Funding Round
United Kingdom, India, United States

Portfolio highlights

Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Bondaval — Bondaval secures receivables for the world's best credit teams, so they can extend more credit, win more business and get better financing terms.
Koos — KOOS is a simple legal and technological solution for motivating and rewarding your community. Boost your growth by sharing success.

Jonathan Lenson

Investment focus

Software, Information Technology, Internet
Seed, Grant, Pre-Seed
United Kingdom, Israel

Portfolio highlights

Fertifa — Fertifa is an innovative employer benefit solution making fertility care more accessible and affordable.The company works with employers to offer a valuable employee benefit which bridges the gap between an employer and their employees when dealing with the sensitivity and privacy of employees’ reproductive issues. It also offers guidance andadvice, next-generation fertility treatment, and access to a range of holistic services for the best chance of success. The company was founded in 2019 and based in London, United Kingdom.
Roleshare — Roleshare matches freelancers, part-time and fractional workers to job share; helping companies retain and attract coveted skills and talent. Join us!
Surfboard — Get Dialpad Workforce Management (WFM) software for accurate forecasting, demand-driven scheduling, fair shift planning, and more.

Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal. Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.

Investment focus

FinTech, Financial Services, Finance
Seed, Series A, Pre-Seed
United Kingdom, United States, Israel

Portfolio highlights

Zelt — Manage everything from HRIS, payroll, pension, devices, apps and more seamlessly in one central hub, for all processes and applications, third-party included. Improve productivity through enhanced employee experience.
Claimer — Claimer is a self-service application that gets credit claims done easily of money spent on research and development. Its platform empowers company owners and advisors to prepare their claims, without any specialist knowledge, no matter how big or small the claim. It also prepares and submits the amended tax return for free.Claimer was founded in2019 by Adam McCann and is headquartered in Croydon, United Kingdom.
Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback

Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014.In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he foundedVisualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004.Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.

Investment focus

Medical Device, Medical, Health Care
Series A, Seed, Angel
United States, United Kingdom

Portfolio highlights

Heru — Discover the future of vision care and virtual eye exams with Heru. Click to learn about our AR eye machines and virtual visual field exams.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
DermaSensor — We've built a handheld, objective device to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds. Early detection saves lives.

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

Investment focus

Internet, Advertising, Social Network
Series A, Series B, Series C
United States, United Kingdom

Portfolio highlights

LovePop — Buy online, personalize, schedule and send 3D pop-up cards with free shipping. Lovepop has greeting cards & paper art for every occasion. A Lovepop is a beautiful keepsake that unfolds like a miniature surprise.
TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.
Vecna Robotics — Vecna Robotics is the leading autonomous mobile robot (AMR) company that provides logistics automation and workflow optimization solutions.

Thomas P. Dyrberg, M.D., Ph.D., serves as Senior Partner of Novo Ventures and Novo A/S. Thomas Dyrberg joined Novo A/S in December 2000, where he was a Partner.He held research positions at the Hagedorn Research Institute, Gentofte, Denmark and at the Scripps Research Institute, La Jolla, California.In 1990, he joined Novo NordiskA/S and worked in health care discovery on various aspects of diabetes immunology and pathogenesis and health Care Clinical Drug Development as an International Clinical Project Manager since 1996. He serves as the Deputy Chairman of Veloxis Pharmaceuticals A/S and has been its Director since September 2003.Thomas Dyrberg has been a Director at Gloucester Pharmaceuticals, Inc. since August 25, 2009. He serves as a Director at Rejuvenon, Corp, Allocure Inc., Veloxis, Lux Biosciences, Inc., Ophthotech Corporation, Sapphire Therapeutics Inc., and Delenex Therapeutics AG.He served as a Director of BioMimetic Therapeutics, Inc. from May 2001 to June 21, 2007. He served as a Director of Helsinn Therapeutics (U.S.), Inc. He has published several articles within the fields of diabetes, immunology, and autoimmunity.Thomas Dyrberg has an M.D. degree in 1981 and his DM.Sc. degree from the University of Copenhagen in 1986.

Investment focus

Biotechnology, Medical, Health Care
Series B, Series C, Seed
United States, United Kingdom, Switzerland

Portfolio highlights

PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.
Freeline — A leading biotechnology company focused on innovative liver directed gene therapies for bleeding disorders and other debilitating, chronic diseases

John Lloyd

Investment focus

Health Care, Education, Wellness
Seed, Funding Round, Equity Crowdfunding
United Kingdom

Portfolio highlights

Thrive — Thrive Mental Wellbeing - Mental Health Services
Easy Peasy — Get EasyPeasy parenting tips and activities, personalised for you and your 0-5 year old, from our playful community of parents and experts.
Elemental Software — Elemental is a digital platform that connects patients health and social care professionals and community health & wellness providers.Health Professionals are able to generate digital social prescriptions for citizens with chronic health risks such as depression, social isolation, type 2 diabetes and obesity, connecting them with qualityassured providers who deliver community based interventions across the domains of exercise, diet/nutrition, social support and mental health.The software is designed as a multi-tenanted cloud service and so can be implemented rapidly. It is highly parameterised and can be customised to suit an individual organisation's functional requirements without compromising its technological core.

Jim Breyer - Co-Founder @ Accel-KKR

Investment focus

Health Care, Software, Information Technology
Series B, Series A, Series C
United States, United Kingdom, Singapore

Portfolio highlights

Zeck — Create smarter, modern board updates optimized for superior readability to better engage and inform your board and investors. Run perfect board meetings.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.
OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.

Flavien Kulawik

Investment focus

Health Care, Artificial Intelligence, SaaS
Seed, Funding Round, Series A
France, United Kingdom

Portfolio highlights

Adionics — Adionics provides advances ionic solutions such as lithium and iodide extraction, and salts separation.
Biomemory — Biomemory creates DNA Drives for large corporates and administrations.
Scienta Lab — Redefining precision immunology

Pa Nolan

Investment focus

Medical, Delivery, Shipping
Seed, Funding Round
Ireland, United Kingdom

Portfolio highlights

SiSaf — SiSaf delivers on the promise of RNA therapeutics with Bio-Courier technology.
Scurri — Scurri is next generation delivery management software that puts retailers back in control. Explore our delivery management software today.

Arthur Chen is a Managing Partner at Ameba Capital.

Investment focus

Medical, Chemical, Software
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

Porotech — All-in-One MicroLEDs for Everyone, Everywhere, Every Device Unleashing the Power of Light Our MicroLED technology revolutionises the way displays are manufactured, making microLED displays possible for everyone. Through our partnerships and dedicated R&D teams we develop new technologies and can succeed together with you. compare to the conventional LED Porotech is here for your every
Pangaea Data — Find & connect with more patients, at scale, for therapies, clinical trials and drug discovery studies.

Emilio Püschmann

Investment focus

Medical, Database, Consulting
Pre-Seed
United Kingdom

Portfolio highlights

OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.

Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.

Investment focus

FinTech, Medical, Wellness
Seed, Pre-Seed
United Kingdom

Portfolio highlights

Dishpatch — Dispatch is a finish-at-home meal kit platform that claims to bring the best of London’s ‘world-beating’ food scene to homes across the UK
Nosso — Nosso is a mobile-based financial planning platform for the future of children.
The Lowdown — 39K Followers, 1,214 Following, 723 Posts - See Instagram photos and videos from The Lowdown (@get.the.lowdown)

Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.

Investment focus

InsurTech, Insurance, Software
Seed, Pre-Seed, Series B
United Kingdom

Portfolio highlights

Hybr — Find your next student accommodation with Hybr, the UK's best student letting platform. Over 5000 happy students served. Click to find your next property.
Lukango — Lukango takes care of your insurance so you can focus on growing your business, knowing your dream is protected in the right way.
Klarytee — Klarytee is a SaaS platform that builds security into sensitive content to enable granular control wherever the data goes

Nicolaus Henke is a senior partner at McKinsey & Company, where he advises leading companies on how to improve decision making and performance through advanced analytics, artificial intelligence, and end-to-end data enabled transformations, and is the global leader of McKinsey Analytics, which has more than 2,000 dedicated analyticspractitioners and translators, where he oversees partnerships between McKinsey and the wider artificial intelligence, data, and computing ecosystem. Nicolaus is the chairman of QuantumBlack (acquired by McKinsey in 2015), a company operating at the intersection of strategy, technology, and design, and a member of McKinsey’s global board, the Shareholder’s Council. He helped found and is a member of the Board of Innovative Healthcare Delivery at Duke Medicine and serves on the Dean’s Advisory Council at Harvard’s Kennedy School. Nicolaus frequently speaks on big data, analytics, and healthcare topics at global forums such as the World Economic Forum, the Milken Institute, and Forbes. He holds a master’s degree and PhD in business from the University of Münster, Germany, and a master’s in public administration from Harvard University, where he was a John J. McCloy Scholar.

Investment focus

Information Technology, SaaS, Medical
Seed, Pre-Seed
United Kingdom

Portfolio highlights

seedata.io — Honeypots, but better! Seedata.io provides cloud-native deception technology to improve threat detection with AI-driven honeypots.
Little Journey — Little Journey supports children and their families before, during and after healthcare interactions, reducing anxiety and improving health outcomes
Oxford Medical Simulation — Drive clinical competency with OMS. Combining healthcare education and competency assessment with dynamic virtual reality simulations.

John Taysom started the Reuters Venture Capital Fund in Palo Alto in 1995 making 82 investments in internet and web infrastructure and services including Verisign, UltraDNS, Digimarc, ZeroKnowledge and Intertrust. He was a member of the Board of Digimarc pre and post its Nasdaq IPO, a Board member at Intertrust and a Board member at TIBCO throughits Nasdaq IPO. To date, seventeen of his investments have achieved an IPO.John acquired the Fund in an MBO in 2002. Now London-based with a seed portfolio of thirty US and UK start-ups; one has achieved an IPO and several have been acquired by Experian, Linkedin, Tesco, BMC and others.In 2011 and 2012 John took a Fellowship at Harvard to work on privacy issues and holds EU and US patents on a method of improving privacy online. For 2015 John is a Policy Fellow at the University of Cambridge Centre for Science and Policy and a Visiting Professor, Department of Computer Science, at UCL. He is a member of the Board of the Web Science Trust; chairs Performance Horizon, a fast growing UK startup; is a Governor at Hurstpierpoint College; and runs a small farm in Devon.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Angel, Series A
United Kingdom, United States

Portfolio highlights

LGN — LGN's edge AI management software puts you in complete technical and financial control of your edge AI systems.
Tenyks — Tenyks gives Computer Vision Engineers the insights to build more reliable models faster! Collaborate to identify and fix dataset issues. Improve data quality. Boost model performance. No more wondering in the dark.
Worldr — Valarian | Innovating for the new era of digital sovereignty

Co-Founder and General Partner in OTB Ventures Graduated from the Warsaw School of Economics and is also Alumni of Stanford University - Graduate School of Business. Founder and CEO of Expander (Poland) as well as Co-Founder of Platinum Bank (Ukraine). Adam Niewiński started his professional career in 1997 at The Boston Consulting Group where heworked as a consultant specialized in financial services sector. As of 2000 he was building a team, acquired financing and subsequently established Expander, which became probably the first polish FinTech. Since 2002 up till 2017 had been associated with the UniCredit Group where he started working in the Central Brokerage House of Bank Pekao S.A. as Deputy CEO responsible for all business activities (investment banking and wealth management). Next, he became CEO of Xelion Investment House – a failed corporate start up that he successfully relaunched to become a leading platform for Personal Financial Advisers with $1b of AuA. In 2015 he was appointed Deputy CEO of Bank PEKAO SA responsible for Private Banking Division as well as Small and Mid Corpo acquisition and financing. He was also the Chairman of the Supervisory Board of Xelion Investment House, Chairman of the Supervisory Board of Private Equity Managers, Deputy Chairman of the Supervisory Board of Central Brokerage House of Bank Pekao S.A., Member of the Supervisory Board of Pekao Investment Banking, and Member of the Management Board of the Society for the Encouragement of Fine Arts by the Zachęta Gallery – National Gallery of Art.

Investment focus

FinTech, Financial Services, Artificial Intelligence
Series A, Seed, Funding Round
Poland, Singapore, United States

Portfolio highlights

ITaxi — ITaxi is a free mobile application, allowing its users to order cabs through its application. Its users do not have to know Polish to use the application as they can decide by type and model of the car, rate per kilometer, and time.ITaxi cooperates with local taxi federations and it has fleet of 10, 000 vehicles in over 100 cities all over thecountry, including Warsaw, Cracow, Lodz, Wroclaw, Gdansk, and Poznan. Launched in 2012 the application is based in Poland.
Credolab — An alternative credit scoring solution based on alternative data (smartphone and web metadata)
Audioteka — Audioteka is a mobile and multi-language audiobook application for smartphones/tablets with a dedicated audiobook car platform. They offer audiobooks in 9 languages in 23 countries.They strive to bring stories back into the lives of busy people through the creative use of technologies. They want everyone to try an audiobook at least once.They're confident you'll enjoy this new medium. People really can be smarter and better entertained thanks to their stories.They edit and produce audiobooks, collaborate with actors, inspire new and innovative productions and in doing so they offer unique content that can’t be found in any other audiobook store. Audioteka strives to give its customers the highest quality content via ready-to-use mobile solutions. They understand their mobile users and continue to learn from them every day. That is why they've created the world's most seamless platform for enjoying valuable spoken word content while on the go!

Henry Engelhardt

Investment focus

Health Care, SaaS, Brewing
Series A, Funding Round, Debt Financing
United States, Australia, United Kingdom

Portfolio highlights

Proximie — Proximie enables healthcare organizations, surgeons, and medical device companies to improve patient safety, scale training efforts, and accelerate device adoption, all while driving substantial savings in cost and time.
UZURV — UZURV is the Adaptive Transportation Network Company serving individuals with disabilities, the elderly, and non-emergency medical transportation needs. It's the efficiency and convenience of rideshare coupled with credentialed, drug and alcohol tested drivers for safe, reliable mobility for the transportation disadvantaged. Our AdaptiveTransportation Network Company (TNC) offers door-to-door service, certified drivers, and driver selection options that provide a high level of care and encourage greater understanding and security between riders and drivers. We be the ADA is more than just a law. It's a Promise and in Mobility Independence for All.
Drop Bear Beer — Drop Bear Beer specializes in creating revolutionary craft beers. The company was founded in 2018 and is headquartered in Swansea, Wales.

1989, Master's in Finance, Univ. of St Gallen, Switzerland; 1991, MBA in Finance, Graduate School of Business, Univ. of Chicago. Former: Partner, private management buy-out group, Switzerland; finance and systems positions, Sandoz and Computerland; finance, operations, management and sales positions, computer and software trading start-upcompanies, Europe, US. 1993, joined QIAGEN, when the company had just 30 employees and revenues of approximately $2 million. Former Member, German Corporate Governance Commission. Director: AdvaMedDx (US in-vitro diagnostics industry organization); ALDA (Analytical, Life Science & Diagnostics Association).

Investment focus

Medical, Genetics, Health Care
Seed
United States, United Kingdom

Portfolio highlights

Valar Labs — AI to Make Oncologists Smarter
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.

Investment focus

FinTech, Software, Health Care
Seed, Angel, Pre-Seed
United Kingdom, Chile

Portfolio highlights

Global 66 — Global 66 is an international online payment platform that allows customers to transfer money with rates up.
Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
Alphagreen Group — Alphagreen Group is a global acquisition and incubation platform with a health & wellness focus. We help brands to scale via our own distribution channels and an extensive external omni-channel network. Build: We build brands using our marketplace and other sources to inform us on consumer demand. We automate the sales of products acrossvarious eCommerce channels, from DTC, on Alphagreen.io, Amazon, affiliates and other channelsAcquire: We acquire high calibre profitable health and wellness brands. We use our data and network to qualify existing products to forecast future growth and automate the management of assets once acquiredScale: We scale brands using our expertise in growth hacking, existing tech infrastructure and an experienced team. Distribution includes via DTC, alphagreen.io and external marketplaces such as Amazon.

Brendan O'Driscoll is the Chief Product Officer of KOHO.

Investment focus

Health Care, Wellness, Artificial Intelligence
Seed, Pre-Seed, Series A
United States, India, United Kingdom

Portfolio highlights

Betterhalf — Best matrimony app in India with AI matchmaking. Get compatible life partner from lakhs of genuine, Govt ID and selfie verified profiles of brides & grooms. Download Betterhalf marriage app now!
Betty Labs — Spotify is a digital music service that gives you access to millions of songs.
Levels — Levels helps you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs)

Sidar Sahin is Founder & CEO at Peak Games.

Investment focus

Medical, mHealth, Health Care
Series A
United Kingdom

Portfolio highlights

Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.

Andrew MacKay

Investment focus

Medical, Hospital, Health Care
Seed
United Kingdom

Portfolio highlights

MyHealthPal — MyHealthPal is a health & wellbeing app to promote healthy living and help you manage your own or other people's health conditions.
Materials Nexus — Accelerating change to net-zero materials

Elan Katz, CEO at Quick RX.

Investment focus

Medical, Health Care, Medical Device
Seed
United Kingdom

Portfolio highlights

TympaHealth — The award-winning Tympa system is designed to empower clinicians to deliver ear and hearing healthcare within local communities.

Robert Taub is the Co-Founder and Chairman at Nyxoah.

Investment focus

Biotechnology, Medical, Hospital
Funding Round, Series A, Series B
Israel, Belgium, United Kingdom

Portfolio highlights

LifeBond — LifeBond is a leader in the development and manufacturing of bio-surgical medical devices for tissue repair that are intended to improve the recovery of patients and to create an environment that supports the body’s natural healing process and promotes tissue repair. Of natural origin, elastic, adhesive, durable and yet absorbable, the company’sdevices can be used to fill a long list of unmet surgical needs. LifeBond’s first product, LifeSeal™, is designed to provide staple-line reinforcement in bariatric and colorectal operations. It was recently studied in an international pilot clinical study in Europe. The company’s second pipeline product, LifeMesh™, a self-fixating hernia mesh, is in pre-clinical development. Other pipeline products include tissue adhesives and absorbable hemostats. LifeSeal™, LifeMesh™ and other LifeBond™ products are investigational and have not yet been approved for sale in the US or in any other market. For more information please visit use at: www.life-bond.com
ARCHIMEDICX — RateCare is the easiest way to understand hospital quality. We rate, rank and benchmark hospitals with a scientific, unbiased method for important decisions. Our system is powered by a unique and HIMSS certified-unbiased algorithm developed by ARCHIMEDICX, which runs on one of the largest hospital procedural databases. Our data and tools areavailable for patients, hospitals and companies needing to make healthcare price/quality decisions. The RateCare team is dedicated to a patient-centric, transparent and sensible approach to measuring Hospital quality and pricing worldwide. Join us on www.ratecare.com
EyeD Pharma — We are EyeD Pharma, a clinical stage pharmaceutical company dedicated to improve the life of patients suffering from ophthalmic diseases.

Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

Sir Nigel Rudd is best known as founder of Williams plc in 1982, which went on to become one of the largest industrial holding companies in the United Kingdom until its demerger in November 2000, creating Chubb plc and Kidde plc. He is presently Chairman of BAA Limited and the technology company Invensys plc, and has been a long-term advocate of afund of this kind. Sir Nigel became Chairman of BGF in February 2011. Sir Nigel was knighted in 1996 for services to manufacturing. He has a long record as an active angel investor in small and medium-sized businesses. He has been Chairman of some of the largest companies in the UK, including Pilkington, Alliance Boots and the UK’s largest car retailer, Pendragon PLC, the company he founded with one dealership in 1982. He was a Director of Barclays PLC for 13 years, latterly as Deputy Chairman.

Investment focus

Health Care, Dental, Medical
Seed, Series A, Series B
United Kingdom

Portfolio highlights

Floe Oral Care — Quality oral care products that are kind to the planet. Designed by dentists and delivered straight to your door. Get started today.
Sky Medical Technology — Sky Medical Technology is a growth-stage bioelectronic medicine platform that completely redefines the way vascular related conditions are treated. The company has developed a neuromodulation therapy called OnPulse™, the first clinically proven bioelectronic compression technology to prevent and treat a wide range of acute and chronic circulatoryconditions. The first indications for the OnPulse wearable therapy are life threatening blood clots, swelling after orthopedic surgery, long term non-healing wounds, as well as applications for pro athletes to speed-up recovery time between games and during travel, conditions experienced by more than forty million people currently with unmet need.

Sachin Agrawal

Investment focus

Medical, Health Care, Health Diagnostics
Series A
United Kingdom

Portfolio highlights

Hexarad — Hexarad is a radiologist-led radiology company, which combines powerful tech and expert people to provide quick, accurate diagnoses. We have developed the Hexarad Platform, a unique and all-encompassing radiology solution powered by an intelligent allocative efficiency engine.

David Prior is the former chair of the UK's National Health Service.

Investment focus

Health Care, Medical, Software
Seed
Belgium, United Kingdom

Portfolio highlights

TORTUS AI — Innovative medical AI which revolutionises the healthcare industry by enhancing clinical operations and patient care. Book a free demo today.
Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.

Johnathan Matlock is Co-Founder Science Angel Syndicate.

Investment focus

Biotechnology, Medical, Health Care
Seed, Pre-Seed, Funding Round
United Kingdom

Portfolio highlights

OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
EnsiliTech — EnsiliTech is a biotechnology start-up developing ensilication, a platform technology, to remove the need for refrigeration when transporting and storing vaccines and biologicals
Halo Therapeutics — Halo Therapeutics is based in England. Develops safe pan coronavirus antiviral drugs for Covid-19 that can be administered by patients.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Health Care, Food and Beverage
Series A, Seed, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Brian Kennedy

Investment focus

Music, Medical, Commercial
Angel, Funding Round
United States, United Kingdom

Portfolio highlights

Gigmor — Booking live music has never been this easy!
Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.

Carlos Ballarati - Founding partner @ Consulta do Bem

Investment focus

Medical, Database, Consulting
Pre-Seed
United Kingdom

Portfolio highlights

OPEN Health — OPEN Health is a healthcare agency that provides market access strategy, health economic modeling and meta-analysis patient engagement, patient-centered outcomes, real-world evidence and data analytics, medical affairs consultancy and strategy, publications planning and delivery, scientific, communications, learning and development.

Yusuf Hamied is a Cambridge-educated Chemist and the Non-Executive Chairman of the Board of Directors at Cipla, a large generic pharmaceuticals company founded in 1935 by his father, Khwaja Abdul Hamied. Yusuf became a global celebrity for his role in defying Western multinational pharmaceutical companies in order to provide generic AIDS treatmentsand other drugs to treat poor people in the developing world. After completing his doctorate in 1960, Yusuf joined the family company and vowed to break the dominance of foreign multinationals over the Indian pharmaceutical market by developing cheap generic drugs. Yusuf helped persuade the Indian government to change Indian patent law in 1972, permitting medicines to be copied even if they were under international patent, as long as the process was not the same. The law transformed the Indian pharmaceutical industry, enabling his and other companies to grow by manufacturing generic drugs. In 2001 Yusuf convulsed the global healthcare industry by promising and then delivering a triple drug cocktail, Triomune, that helped fight against HIV and AIDS at prices far lower than those available internationally. Yusuf discusses his subsequent anger when, in 2005, the Indian government brought its patent laws in line with those of the developed world, prohibiting the copying of drugs patented after 1995 without a license and his resentment that he had thereafter “to go with a begging bowl to the multinationals” for licenses. This interview provides not only a personal perspective on how India’s third largest pharmaceutical firm was created, but contributes to the broad debates on the costs and benefits of intellectual property laws, particularly their impact on people who are denied life-saving drugs by their inability to pay for them. Working for Cipla as Managing Director for nearly 52 years, Yusuf was also the 28th richest Indian during one time. ‘CNN-IBN Indian of the year’ and one among the ’25 greatest global living legends’ were the titles that Yusuf won for his reign in the pharma world majorly for making medicines affordable to the poor. Yusuf was awarded with the civil honorary Padma Bhushan from then president APJ Abdul Kalam in the year 2005 for his fight against AIDS, which he often said was going to be as damaging to the society as a massive earthquake would be, if ignored. Yusuf earned his Bachelor's degree (1956), Master's degree (1957) and Ph.D. (1960) in Chemistry from University of Cambridge.

Investment focus

Medical, Medical Device
Seed
United Kingdom

Portfolio highlights

1inhaler — 1inhaler operates as a developer of drug delivery device.

Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.

Investment focus

Medical, Commercial, Health Care
Funding Round
United Kingdom

Portfolio highlights

Ryboquin — Ryboquin™ uses its expertise to turn under-developed intellectual property ideas into viable commercial realities. Founded in Scotland, Ryboquin Ltd is a privately held, virtual pharmaceutical company focused on commercialising patented technologies in the area of human cancer medicine.Founded in Scotland, Ryboquin is a privately held, virtualpharmaceutical company focused on commercializing patented technologies in the area of human cancer medicine.

Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.

Investment focus

Medical Device, Health Care, Medical
Seed, Series A, Angel
United States, United Kingdom, The Netherlands

Portfolio highlights

Mendaera — Mendaera enables all healthcare providers to perform precise and consistent point-of-care interventions. Their platform combines real-time imaging, robotics, and artificial intelligence to aid physicians in image acquisition and interpretation.
Bright Uro — Actionable Insight Improves Outcomes
Proclaim — Proclaim is a revolutionary, at-home, custom-jet oral irrigator that provides patients with the easiest, fastest, most effective at-home oral care.

Graduate, Harvard Univ. and Harvard Business School. Chairman and Managing Director, Mahindra Group. Thought leader in Indian business. Serves on many industry confederations. Initiated the Nanhi Kali programme to provide free education to economically underprivileged girls in India. Co-Founder, Naandi Danone, India's largest safe drinkingwater provider to rural areas. Life Trustee, Board of Naandi Foundation, which provides meals to 1.3 million children daily. Co-Chair, World Economic Forum Annual Meeting 2009. Named among World’s 50 Greatest Leaders, Fortune Magazine (2014); named one of the top 25 most powerful business people in Asia, Fortune Magazine (2011).

Investment focus

Education, Artificial Intelligence, Social Media
Seed, Angel, Series A
India, United States, United Kingdom

Portfolio highlights

Agnikul — Agnikul Cosmos designs and manufactures orbital-class launch vehicles powered by 3D-printed engines. From custom payloads to affordable private launches, we make space access simple, scalable, and mission-focused.
Harvested Robotics — Harvested Robotics is an ag-tech company that focuses on safeguarding farms from weeds and diseases by lasers, robotics, and AI technology.
Genrobotics Medical & Mobility — India's top-rated gait trainer, G Gaiter! Our AI-powered, robot assisted gait trainer accelerates neurorehabilitation for faster recovery.

Principal at Apax Digital.

Investment focus

Rental, Medical, Software
Series A, Series D, Series E
Israel, United Kingdom

Portfolio highlights

Guesty — Guesty simplifies the way property managers work.
MIP Diagnostics — MIP Diagnostics develop and manufacture molecularly imprinted polymers (nanoMIPs) that act as synthetic alternatives to antibodies for IVD and other industries.

Investors by industry

Community

Artificial intelligence